Questionnaire Study for Gynecological Cancer Survivors
Gynecologic Cancer Survivorship Survey
1 other identifier
observational
1,000
1 country
2
Brief Summary
The purpose of this study is to evaluate the quality of life of long-term gynecologic cancer survivors.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Feb 2006
Longer than P75 for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2006
CompletedFirst Submitted
Initial submission to the registry
October 23, 2006
CompletedFirst Posted
Study publicly available on registry
October 24, 2006
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2011
CompletedJune 30, 2008
June 1, 2008
October 23, 2006
June 26, 2008
Conditions
Keywords
Interventions
Eligibility Criteria
You may qualify if:
- Female participants diagnosed with gynecologic cancer
- Participants between the ages of 20 and 75 years old, inclusive
- Participants previously treated for all stages (I-IV) of the following cancers: cervix; endometrium; ovary; vulva; vagina; and other genital cancers
- Participants receiving treatment for their primary cancer in the past 2-10 years
You may not qualify if:
- Male participants
- Participants with major psychoses (e.g. organic brain syndrome; schizophrenia; bipolar disorder; or mental retardation).
- Participants with significant hearing deficit
- Participants with prior non-gynecologic cancer diagnosis
- Participants who refused all forms of cancer treatment, whether standard of care or experimental.
- Participants with deficient ability to read/speak English
- Participants residing \>90 miles from the research site
- Participants diagnosed with dementia
- Participants diagnosed with pregnancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- U.S. Army Medical Research and Development Commandlead
- Walter Reed Army Medical Centercollaborator
- Ohio State Universitycollaborator
Study Sites (2)
Walter Reed Army Medical Center
Washington D.C., District of Columbia, 20307, United States
Ohio State University
Columbus, Ohio, 43210, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Barbara L Andersen, PhD
Ohio State University
- PRINCIPAL INVESTIGATOR
LTC G. Larry Maxwell, MD
Walter Reed Army Medical Center
Central Study Contacts
Study Design
- Study Type
- observational
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- FED
Study Record Dates
First Submitted
October 23, 2006
First Posted
October 24, 2006
Study Start
February 1, 2006
Study Completion
February 1, 2011
Last Updated
June 30, 2008
Record last verified: 2008-06